Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.

MLA

de Sousa, Gideon John, et al. “Type 1 Diabetes and Epilepsy in Childhood and Adolescence: Do Glutamic Acid Decarboxylase Autoantibodies Play a Role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.” Pediatric Diabetes, vol. 21, no. 5, Aug. 2020, pp. 766–73. EBSCOhost, https://doi.org/10.1111/pedi.13034.

APA

de Sousa, G. J., Tittel, S. R., Häusler, M., Holterhus, P. M., Berger, G., Holder, M., Kamrath, C., Golembowski, S., Herrlinger, S., & Holl, R. W. (2020). Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry. Pediatric Diabetes, 21(5), 766–773. https://doi.org/10.1111/pedi.13034

Chicago

de Sousa, Gideon John, Sascha René Tittel, Martin Häusler, Paul Martin Holterhus, Gabriele Berger, Martin Holder, Clemens Kamrath, Sven Golembowski, Silke Herrlinger, and Reinhard Walter Holl. 2020. “Type 1 Diabetes and Epilepsy in Childhood and Adolescence: Do Glutamic Acid Decarboxylase Autoantibodies Play a Role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.” Pediatric Diabetes 21 (5): 766–73. doi:10.1111/pedi.13034.